Evelo Biosciences, Inc.
EVLODelisted Dec 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001694665
Evelo Biosciences, Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Nov 8, 2023; 29 institutions reported holding it in 13F filings for Q3 2023, worth $52.0M in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Evelo Biosciences, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 64 | 1 | 66 | +3 |
| Shares | 47.1M | 113.8K | 47.8M | +870.3K (+1.9%) |
| Value | $331.6M | $802.0K | $290.1M | −$40.7M (−12.3%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held Evelo Biosciences, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Group One Trading, L.P. | 126,309 | $767.0K | 0.01% |
| Citadel Advisors LLC | 57,773 | $351.0K | 0.00% |
| Alberta Investment Management Corp | 40,000 | $243.0K | 0.00% |
| Susquehanna Fundamental Investments, LLC | 24,602 | $149.0K | 0.00% |
| ProShare Advisors LLC | 14,162 | $86.0K | 0.00% |
| Alpine Global Management, LLC | 14,194 | $86.0K | 0.01% |
| Quantbot Technologies LP | 3,600 | $21.0K | 0.00% |
| Advisor Group Holdings, Inc. | 750 | $5.00K | 0.00% |
| High Net Worth Advisory Group LLC | 500 | $3.00K | 0.00% |
| National Bank of Canada | 100 | $1.00K | 0.00% |
| Daiwa Securities Group Inc. | 156 | $1.00K | 0.00% |
| Signaturefd, LLC | 78 | $0 | 0.00% |
Sold out (9)
Institutions that held Evelo Biosciences, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Marshall Wace, LLP | 38,807 | $273.0K |
| AQR Capital Management LLC | 24,325 | $171.0K |
| Gsa Capital Partners LLP | 11,624 | $82.0K |
| Jane Street Group, LLC | 11,266 | $79.0K |
| SG Americas Securities, LLC | 10,454 | $74.0K |
| Meeder Asset Management Inc | 8,858 | $61.0K |
| Banque Cantonale Vaudoise | 2,500 | $18.0K |
| Sandy Spring Bank | 565 | $4.00K |
| Jefferies Group LLC | 33 | $232 |
Not filed for Q4 2021 yet (1)
Institutions that held Evelo Biosciences, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Trustees of Columbia University in the City of New York | 113,850 | $802.0K |